Loading…

to bookmark your favorites and sync them to your phone or calendar.
arrow_back View All Dates
Wednesday, January 15
 

8:00am PST

Networking Breakfast
Wednesday January 15, 2025 8:00am - 8:50am PST
Hyatt Regency San Francisco
Wednesday January 15, 2025 8:00am - 8:50am PST
Hyatt Regency San Francisco
  Networking

8:00am PST

Registration
Wednesday January 15, 2025 8:00am - 3:00pm PST
Hyatt Regency San Francisco
Wednesday January 15, 2025 8:00am - 3:00pm PST
Hyatt Regency San Francisco

8:50am PST

Opening Remarks
Wednesday January 15, 2025 8:50am - 9:00am PST
Hyatt Regency San Francisco
Speakers
avatar for Stephanie Butler

Stephanie Butler

Senior Conference Production Director, Fierce Life Sciences
Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences.  Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life... Read More →
Wednesday January 15, 2025 8:50am - 9:00am PST
Hyatt Regency San Francisco

9:00am PST

Industry Keynote
Wednesday January 15, 2025 9:00am - 9:20am PST
Hyatt Regency San Francisco
Wednesday January 15, 2025 9:00am - 9:20am PST
Hyatt Regency San Francisco
  Keynote

9:20am PST

How can the Combination of Agentic and Human Intelligence Transform Drug Discovery, Development, and Diagnostics?
Wednesday January 15, 2025 9:20am - 9:50am PST
Hyatt Regency San Francisco
This panel will explore how agentic AI and human intelligence will transform drug development, from early-stage discovery and target identification to optimizing clinical trials and advancing personalized treatments. Key topics include AI’s role in accelerating research, improving trial design, and enhancing patient recruitment. The discussion will also address the challenges of understanding complex biology, ensuring data quality, and fostering cross-industry collaboration. By harnessing collective intelligence, the panel will highlight how these technologies can drive innovation, efficiency, and personalization across the drug development pipeline by harnessing collective intelligence.
Moderators
avatar for Stephanie Butler

Stephanie Butler

Senior Conference Production Director, Fierce Life Sciences
Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences.  Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life... Read More →
Speakers
TC

Thomas Clozel

CEO, Owkin
JR

Jorge Reis-Filho

Vice-President, Cancer Biomarker Development, AstraZeneca
Wednesday January 15, 2025 9:20am - 9:50am PST
Hyatt Regency San Francisco
  Keynote

9:50am PST

Panel: Biotech Markets and IPOs: Trends from 2024 and Projections for 2025
Wednesday January 15, 2025 9:50am - 10:30am PST
Hyatt Regency San Francisco
The biotech market made a comeback in 2024, recovering from a slump a year earlier. What will the IPO window look like in 2025? During this panel discussion, we will examine the performance of companies that went public in the second half of 2024 and how their success or challenges are impacting other startups’ decisions on whether to go public themselves
Moderators
avatar for Gabrielle Masson

Gabrielle Masson

Associate Editor, Fierce Biotech
Gabrielle Masson is an associate editor for Fierce Biotech. Prior to Fierce, she worked at Becker's Hospital Review, where she reported on public health and the pandemic. Gabrielle graduated from the University of Wisconsin-Madison after studying creative writing and criminal justice... Read More →
Speakers
CD

Chirag D. Surti

Executive Director, Morgan Stanley
avatar for Maha Katabi

Maha Katabi

General Partner, Sofinnova Investments
avatar for Troy Ignelzi

Troy Ignelzi

CFO, Rapport Therapeutics
Troy has nearly two decades of financial leadership experience in the biotech and pharmaceuticals sectors. Over the course of his career, Troy has raised an impressive $4 billion-plus in capital for life science companies. Most recently, he was Chief Financial Officer at Karuna Therapeutics... Read More →
Wednesday January 15, 2025 9:50am - 10:30am PST
Hyatt Regency San Francisco
  Panel
  • Qtag Featured

10:30am PST

Networking Break
Wednesday January 15, 2025 10:30am - 11:00am PST
Hyatt Regency San Francisco
Wednesday January 15, 2025 10:30am - 11:00am PST
Hyatt Regency San Francisco
  Networking

11:00am PST

Executive Interview
Wednesday January 15, 2025 11:00am - 11:20am PST
Hyatt Regency San Francisco
Wednesday January 15, 2025 11:00am - 11:20am PST
Hyatt Regency San Francisco
  Executive Interview

11:20am PST

Partner Presentation
Wednesday January 15, 2025 11:20am - 11:40am PST
Hyatt Regency San Francisco
Wednesday January 15, 2025 11:20am - 11:40am PST
Hyatt Regency San Francisco
  Presentation

11:40am PST

Panel: Unlocking the Power of Healthcare Data: Advancing Access and Connectivity to Drive Patient Outcomes
Wednesday January 15, 2025 11:40am - 12:20pm PST
Hyatt Regency San Francisco
As healthcare embraces a more connected future, the need for real-time, global data access has become vital to bridging gaps in patient care and streamlining drug development. This panel delves into the challenges and opportunities in democratizing healthcare data, with a focus on integrated solutions and strategies that address data fragmentation and enable swift access to diverse patient and provider demographics. Join us to discover how democratizing healthcare data will shape the future of global patient care and catalyze advancements in the biopharma industry.
Moderators
avatar for Stephanie Butler

Stephanie Butler

Senior Conference Production Director, Fierce Life Sciences
Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences.  Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life... Read More →
Speakers
avatar for Jeffrey Helterbrand, Ph.D.

Jeffrey Helterbrand, Ph.D.

SVP, Data Sciences, Roche
Jeff is a Senior Vice President in PD Data Sciences (formerly Biometrics) at Roche. Data Sciences at Roche includes statisticians, patient-centered outcomes researchers, statistical programmers, clinical data managers, and medical data and information solution teams. Jeff is a member... Read More →
Wednesday January 15, 2025 11:40am - 12:20pm PST
Hyatt Regency San Francisco
  Panel

12:20pm PST

Networking Lunch
Wednesday January 15, 2025 12:20pm - 1:20pm PST
Hyatt Regency San Francisco
Wednesday January 15, 2025 12:20pm - 1:20pm PST
Hyatt Regency San Francisco
  Networking

1:20pm PST

Panel: End of the Conglomerate Era
Wednesday January 15, 2025 1:20pm - 2:00pm PST
Hyatt Regency San Francisco
Across the medtech industry, some of the largest players have shed entire divisions as they seek to narrow their focus on their core businesses. These moves range from J&J spinning out its Kenvue consumer operations, to Baxter selling off its multibillion-dollar kidney care unit, to GE HealthCare keeping the name of its conglomerate parent as it became an independent company. During this panel, we’ll explore the forces driving these divestitures and their effects on competition, branding, M&A and the broader market landscape—as well as whether elder firms have found success with smaller portfolios, and if the newcomers have found their footing.
Moderators
avatar for Conor Hale

Conor Hale

FierceMedTech, Senior Editor
Conor Hale is a senior editor writing for FierceMedTech and FierceBiotech. He has previously covered the pharmaceutical and medical research industries in the Washington, D.C., area for The Cancer Letter and FDAnews. Conor graduated from St. Bonaventure University’s journalism school... Read More →
Speakers
avatar for Rachel Ellingson

Rachel Ellingson

Senior Vice President, Chief Administrative Officer, Zimmer Biomet
Rachel Ellingson was appointed Senior Vice President, Chief Administrative Officer in June 2024. In her role, she is responsible for strategy, business development (M&A execution and integration, strategic partnerships, divestitures and minority investments), marketing and communications... Read More →
GB

Ginny Block

SVP, Global Marketing & Product Management, embecta
avatar for Arda Ural, PhD

Arda Ural, PhD

Americas Life Sciences Leader, Ernst & Young LLP
Arda Ural, PhD is the EY Americas Life Sciences Sector Leader. In this role, he is in service to EY life sciences professionals in North and South America, helping them to solve our clients’ most pressing issues at the C-suite level, building a sector community and upholding the... Read More →
avatar for Brian Montgomery

Brian Montgomery

Chief Strategy Officer, GE HealthCare
Brian leads Strategy for GE HealthCare, responsible for accelerating GE HealthCare’s strategic goals and leading the business development function.Immediately prior to his appointment, Brian was the acting Chief Financial Officer of GE HealthCare from June 2020 after serving as... Read More →
Wednesday January 15, 2025 1:20pm - 2:00pm PST
Hyatt Regency San Francisco
  Executive Interview

2:00pm PST

Partner Presentation
Wednesday January 15, 2025 2:00pm - 2:20pm PST
Hyatt Regency San Francisco
Wednesday January 15, 2025 2:00pm - 2:20pm PST
Hyatt Regency San Francisco
  Presentation

2:20pm PST

Executive Interview: Quita Highsmith, Vice President and Chief Diversity Officer, Genentech
Wednesday January 15, 2025 2:20pm - 2:40pm PST
Hyatt Regency San Francisco
Speakers
avatar for Quita Highsmith

Quita Highsmith

Vice President and Chief Diversity Officer, Genentech
Quita Highsmith is Vice President and Chief Diversity Officer at Genentech, a member of the Roche Group. At Genentech Quita was selected as the first Chief Diversity Officer in the 46-year history of the company and reports to the CEO. She is responsible for enterprise-wide strategic... Read More →
Wednesday January 15, 2025 2:20pm - 2:40pm PST
Hyatt Regency San Francisco
  Executive Interview

2:40pm PST

Panel: Cell & Gene Therapy: Challenges, Trends and Technologies
Wednesday January 15, 2025 2:40pm - 3:20pm PST
Hyatt Regency San Francisco
With advancements in platform technologies and automation, the cell and gene therapy space is poised for changes. During this panel discussion, industry leaders will explore challenges and share insights on navigating regulatory hurdles, optimizing manufacturing and leveraging emerging technologies to address broader disease states.
Moderators
avatar for Fraiser Kansteiner

Fraiser Kansteiner

Staff Writer, Fierce Pharma
Fraiser Kansteiner is a staff writer at Fierce Pharma. He joined the Fierce team in 2020 and covers topics such as manufacturing, COVID-19 and drug delivery. He also manages Fierce Biotech and Fierce Pharma’s LinkedIn showcase pages. Before diving into pharma reporting, Fraiser... Read More →
Speakers
avatar for Dr. Nadir Mahmood

Dr. Nadir Mahmood

President, Nkarta
Dr. Nadir Mahmood serves as President of Nkarta, where he is responsible for driving the company’s strategic focus, business excellence, and technical success. He previously served as the Chief Executive Officer of Rezo Therapeutics, a private-stage drug discovery company. Prior... Read More →
avatar for Richard Wilson

Richard Wilson

SVP, Primary Focus Lead Genetic Regulation, Astellas
Richard Wilson, Senior Vice President, Primary Focus Lead of Genetic Regulation at Astellas Gene Therapies, is responsible for setting and leading the gene therapy strategy for Astellas’ Primary Focus Genetic Regulation. Richard joined Astellas Gene Therapies (formerly Audentes... Read More →
avatar for Christopher Arendt, Ph.D.

Christopher Arendt, Ph.D.

Chief Scientific Officer, Head of Research, Takeda
Based at Takeda’s Cambridge, Massachusetts, R&D campus, Christopher Arendt is responsible for oversight of Takeda’s Research and Early Development portfolio across Takeda’s core therapeutic areas of Gastroenterology andInflammation, Oncology, and Neuroscience.  Prior to his... Read More →
avatar for Cindy Perettie

Cindy Perettie

Executive Vice President, Kite, a Gilead Company
Cindy Perettie serves as Executive Vice President of Kite, a Gilead Company, and is responsible for overseeing the cell therapy business. Cindy joined Kite in 2023 with more than 20 years of scientific and commercial leadership experience in global biopharmaceutical organizations... Read More →
Wednesday January 15, 2025 2:40pm - 3:20pm PST
Hyatt Regency San Francisco
  Panel
  • Qtag Featured

3:20pm PST

Closing Remarks
Wednesday January 15, 2025 3:20pm - 3:30pm PST
Hyatt Regency San Francisco
Speakers
avatar for Stephanie Butler

Stephanie Butler

Senior Conference Production Director, Fierce Life Sciences
Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences.  Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life... Read More →
Wednesday January 15, 2025 3:20pm - 3:30pm PST
Hyatt Regency San Francisco
 
Share Modal

Share this link via

Or copy link

Filter sessions
Apply filters to sessions.
Filtered by Date - 
Clear filter
Tuesday, January 14
Wednesday, January 15
Hyatt Regency San Francisco
  • Executive Interview
  • Keynote
  • Networking
  • Panel
  • Presentation